Literature DB >> 8597448

The role of CRF in behavioral aspects of stress.

S C Heinrichs1, F Menzaghi, E Merlo Pich, K T Britton, G F Koob.   

Abstract

CRF in the central nervous system appears to hve activating properties on behavior and to coordinate behavioral responses to stressors. These behavioral effects of CRF appear to be independent of the pituitary-adrenal axis and can be reversed by CRF antagonists. CRF antagonist administration reverses not only decreases in behavior associated with stress, but also increases in behavior associated with stress, thus suggesting that the role of CRF is stress dependent and not intrinsic to a given behavioral response. Further, microinjection of alpha-helical CRF 9-41 and immunotargeting of CRF neurons in separate brain compartments reveal a link between the anatomical sites that contain CRF and the nature of the behavioral response to stressors that can be modified by suppression of endogenous CRF activity therein. These actions of CRF in coordinating coping responses to stress at several bodily levels are consistent with a role for CRF similar to the dual role of other hypothalamic releasing factors in integrating hormonal and neural mechanisms by acting both as secretagogues for anterior pituitary hormones and as extrapituitary peptide neurotransmitters. Moreover, dysfunction in such a fundamental homeostatic system may be the key to a variety of pathophysiological conditions including mental disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8597448     DOI: 10.1111/j.1749-6632.1995.tb44673.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  53 in total

Review 1.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

2.  Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis.

Authors:  Maya Lebow; Adi Neufeld-Cohen; Yael Kuperman; Michael Tsoory; Shosh Gil; Alon Chen
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

3.  The psychomodulatory action of subpyrogenic doses of interleukin-1beta in conditions of chronic administration to rats.

Authors:  E S Sokolova; V I Lyudyno; A S Simbirtsev; V M Klimenko
Journal:  Neurosci Behav Physiol       Date:  2007-06

4.  Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects.

Authors:  Melissa A Herman; Florence P Varodayan; Christopher S Oleata; George Luu; Dean Kirson; Markus Heilig; Roberto Ciccocioppo; Marisa Roberto
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

Review 5.  Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain.

Authors:  T Z Baram; C G Hatalski
Journal:  Trends Neurosci       Date:  1998-11       Impact factor: 13.837

Review 6.  The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

Authors:  Barbara Stanley; Larry J Siever
Journal:  Am J Psychiatry       Date:  2009-12-01       Impact factor: 18.112

7.  Social isolation induces behavioral and neuroendocrine disturbances relevant to depression in female and male prairie voles.

Authors:  Angela J Grippo; Davida Gerena; Jonathan Huang; Narmda Kumar; Maulin Shah; Raj Ughreja; C Sue Carter
Journal:  Psychoneuroendocrinology       Date:  2007-09-07       Impact factor: 4.905

8.  Nesfatin-1 increases anxiety- and fear-related behaviors in the rat.

Authors:  Z Merali; C Cayer; P Kent; H Anisman
Journal:  Psychopharmacology (Berl)       Date:  2008-08-01       Impact factor: 4.530

9.  Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural evidence for dopaminergic control of amygdaloid stress systems.

Authors:  Marina Eliava; Deniz Yilmazer-Hanke; Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-08-09       Impact factor: 4.304

10.  CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.

Authors:  Michael R Bruchas; Benjamin B Land; Julia C Lemos; Charles Chavkin
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.